RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 4519.T
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for CHUGAI PHARMACEUTICAL CO.,LTD. stock price after Tuesday trading.
(Updated on Apr 30, 2024)

Sell candidate since Apr 19, 2024 Gain 2.62% PDF

The CHUGAI PHARMACEUTICAL CO.,LTD. stock price gained 4.08% on the last trading day (Tuesday, 30th Apr 2024), rising from JP¥4,852.00 to JP¥5,050.00. During the last trading day the stock fluctuated 2.23% from a day low at JP¥4,968.00 to a day high of JP¥5,079.00. The price has been going up and down for this period, and there has been a -1.08% loss for the last 2 weeks. Volume fell on the last day by -2 million shares and in total, 3 million shares were bought and sold for approximately JP¥14.01 billion. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at JP¥4,842.40 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -8.52% during the next 3 months and, with a 90% probability hold a price between JP¥4,429.73 and JP¥5,655.22 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

4519.T Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has risen 4.08%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The CHUGAI PHARMACEUTICAL CO.,LTD. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at JP¥5,559.54. On a fall, the stock will find some support from the short-term average at JP¥5,024.14. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for CHUGAI PHARMACEUTICAL CO.,LTD. stock

CHUGAI PHARMACEUTICAL CO.,LTD. finds support from accumulated volume at JP¥4,921.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved JP¥111.00 between high and low, or 2.23%. For the last week, the stock has had daily average volatility of 3.64%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (4519.T) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect CHUGAI PHARMACEUTICAL CO.,LTD. to open at JP¥5,032.33, and during the day (based on 14 day Average True Range), to move between JP¥4,869.58 and JP¥5,230.42, which gives a possible trading interval of +/-JP¥180.42 (+/-3.57%) up or down from last closing price. If CHUGAI PHARMACEUTICAL CO.,LTD. takes out the full calculated possible swing range there will be an estimated 7.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at JP¥4,921.00 (2.55%) than the resistance at JP¥5,237.00 (3.70%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is CHUGAI PHARMACEUTICAL CO.,LTD. stock A Buy?

CHUGAI PHARMACEUTICAL CO.,LTD. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -2.432 Sell Candidate Upgraded

Predicted Opening Price for CHUGAI PHARMACEUTICAL CO.,LTD. of Wednesday, May 1, 2024

Fair opening price May 1, 2024 Current price
JP¥5,032.33 ( 0.350%) JP¥5,050.00

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 4519.T

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5,143.33 1.85 %
R2 5,100.93 1.01 %
R1 5,074.74 0.490 %
Current price: 5,050.00
Support S1 4,989.93 -1.19 %
S2 4,963.74 -1.71 %
S3 4,921.33 -2.55 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 6,000.00 18.81 %
R2 5,648.00 11.84 %
R1 5,237.00 3.70 %
Current price 5,050.00
Support S1 4,921.00 -2.55%
S2 4,860.00 -3.76%
S3 4,852.00 -3.92%

4519 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 27, 2024 Jun 27, 2024 Jun 27, 2024 JP¥0 0%
2 Jun 29, 2023 Jun 29, 2023 Jun 29, 2023 JP¥40.00 0.96%
3 Dec 29, 2022 Dec 29, 2022 Dec 29, 2022 JP¥40.00 1.18%
4 Jun 29, 2022 Jun 29, 2022 Jun 29, 2022 JP¥38.00 1.08%
5 Dec 29, 2021 Dec 29, 2021 Dec 29, 2021 JP¥46.00 1.22%

FAQ

What is the symbol for CHUGAI PHARMACEUTICAL CO.,LTD. Stock and on which exchange is it traded?
The symbol for CHUGAI PHARMACEUTICAL CO.,LTD. is 4519.T and it is traded on the TYO (Tokyo Stock Exchange).

Should I buy or sell CHUGAI PHARMACEUTICAL CO.,LTD. Stock?
CHUGAI PHARMACEUTICAL CO.,LTD. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy CHUGAI PHARMACEUTICAL CO.,LTD. Stock?
CHUGAI PHARMACEUTICAL CO.,LTD. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CHUGAI PHARMACEUTICAL CO.,LTD. Stock.

What's the current price of CHUGAI PHARMACEUTICAL CO.,LTD. Stock?
As of the end of day on the Apr 30, 2024, the price of an CHUGAI PHARMACEUTICAL CO.,LTD. (4519.T) share was JP¥5,050.00.

What is the 52-week high and low for CHUGAI PHARMACEUTICAL CO.,LTD. Stock?
The 52-week high for CHUGAI PHARMACEUTICAL CO.,LTD. Stock is JP¥6,697.00 and the 52-week low is JP¥3,515.00.

What is the market capitalization of CHUGAI PHARMACEUTICAL CO.,LTD. Stock?
As of the Apr 30, 2024, the market capitalization of CHUGAI PHARMACEUTICAL CO.,LTD. is 7.983T.

When is the next earnings date for CHUGAI PHARMACEUTICAL CO.,LTD.?
The upcoming earnings date for CHUGAI PHARMACEUTICAL CO.,LTD. is Jul 25, 2024.
Click to get the best stock tips daily for free!

About CHUGAI PHARMACEUTICAL CO.,LTD.

CHUGAI PHARMACEUTICAL Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and ne... 4519.T Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT